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ﺓﺩﺎﻀﻣﻲﺗﺎﺒﻧﻞﺻﺃﺕﺍﺫﺔﻴﺋﺎﻤﻴﻛﺕﺎﺒﻛﺮﻣﻰﻠﻋﺔﻟﻭﺍﺮﻔﻟﺍﺭﺎﻤﺛﻱﻮﺘﺤﺗ:ﻑﺍﺪﻫﻷﺍ
،ﻥﺎﻃﺮﺴﻟﺍﻭ،ﺐﻠﻘﻟﺍﺽﺍﺮﻣﺃﻭﺕﺎﺑﺎﻬﺘﻟﻻﺍﺪﺿﺓﺪﻴﻔﻣﺕﺎﺒﻛﺮﻤﻟﺍﻩﺬﻫﺮﺒﺘﻌﺗﻭ.ﺓﺪﺴﻛﻸﻟ
ﻦﻋﺔﺠﺗﺎﻨﻟﺍﺕﺎﻔﻋﺎﻀﻤﻟﺍﻭﻡﺪﻟﺍﻲﻓﺮﻜﺴﻟﺍﻉﺎﻔﺗﺭﺍﻭ،ﻲﺒﺼﻌﻟﺍﺲﻜﻨﺘﻟﺍﻭ،ﺔﻨﻤﺴﻟﺍﻭ
ﺭﺎﻤﺜﻟﺍﻩﺬﻬﻟﺪﻤﺠﻤﻟﺍﻭﻒﻔﺠﻤﻟﺍﻕﻮﺤﺴﻤﻟﺍﻙﻼﻬﺘﺳﺍﺮﺒﺘﻌﻳﻭ.ﻱﺮﻜﺴﻟﺍﺀﺍﺪﺑﺔﺑﺎﺻﻹﺍ
ﻲﻓﺎﻬﺘﻴﻟﺎﻌﻓﻰﻟﺇﺔﻓﺎﺿﻹﺎﺑ(ﺾﻳﻷﺍ)ﺏﻼﻘﺘﺳﻻﺍﺀﻮﺳﺔﻣﺯﻼﺘﻣﺔﺠﻟﺎﻌﻣﻲﻓﻻﺎﻌﻓ
.ﻦﻴﻳﺍﺮﺸﻟﺍﻭﺐﻠﻘﻟﺍﺽﺍﺮﻣﻷﺔﺒﺣﺎﺼﻤﻟﺍﺓﺭﻮﻄﺨﻟﺍﻞﻣﺍﻮﻋﻭﻞﻛﺎﺸﻣﺔﺠﻟﺎﻌﻣﻭﺐﻠﻐﺘﻟﺍ
ﻱﺮﻜﺴﻟﺍﺽﺮﻣﻰﻠﻋﺪﻤﺠﻤﻟﺍﻭﻒﻔﺠﻤﻟﺍﺔﻟﻭﺍﺮﻔﻟﺍﻕﻮﺤﺴﻣﺮﻴﺛﺄﺗﺔﺳﺍﺭﺪﻟﺍﻩﺬﻫّﻢﻴﻘﺗ
.ﺏﺭﺎﺠﺘﻟﺍﺮﺒﺘﺨﻣﻲﻓﻥﺍﺮﺌﻔﻟﺍﻰﻠﻋﻥﺎﺴﻛﻮﻟﻷﺎﺑﺎﻴﻠﻤﻌﻣﺰﻔﺤﻤﻟﺍ
ﻱﺩﺎﺣﺃﻥﺎﺴﻛﻮﻟﻷﺍﺓﺩﺎﻤﺑﻕﺎﻔﺼﻟﺍﻞﺧﺍﺩﻥﺍﺮﺌﻔﻟﺍﺭﻮﻛﺫﻦﻘﺣﻢﺗ:ﺚﺤﺒﻟﺍﻕﺮﻃ
ﻢﺛ.ﻥﺍﺮﺌﻔﻟﺍﻥﺯﻭﻦﻣﻢﺠﻠﻛ/ﻢﺠﻠﻣ٠٥١ﺔﻋﺮﺠﺑﻱﺮﻜﺴﻟﺍﺀﺍﺪﻟﺔﺒﺒﺴﻤﻟﺍﺔﻫﺎﻣﻹﺍ
ًﺎﻣﻮﻳ٥٤ﺓﺪﻤﻟﻢﺠﻠﻣ٠٠٧ﻝﺪﻌﻤﺑﺓﺪﻤﺠﻤﻟﺍﻭﺔﻔﻔﺠﻤﻟﺍﺔﻟﻭﺍﺮﻔﻟﺎﺑﻥﺍﺮﺌﻔﻟﺍﻩﺬﻫﺖﺠﻟﻮﻋ
ﺔﻘﻴﻗﺪﻟﺍﺔﻴﻠﻤﻌﻤﻟﺍﺕﺎﺳﺎﻴﻘﻟﺍﺕﺬﺧﺃﻢﺛ.ﻥﺎﺴﻛﻮﻟﻷﺍﺐﻛﺮﻤﺑﻦﻘﺤﻟﺍﻦﻣﺔﻋﺎﺳ٨٤ﺪﻌﺑ
ﻒﺋﺎﻇﻭﻭ،ﻦﻴﺑﻮﻠﺟﻮﻤﻴﻬﻟﺍﻭ،ﺝ-ﺪﻴﺘﺒﺒﻟﺍﻭ،ﻦﻴﻟﻮﺴﻧﻷﺍﻭ،ﻡﺪﻟﺎﺑﺮﻜﺴﻟﺍﺔﺒﺴﻧﺮﻳﺪﻘﺘﻛ
ﺪﺒﻜﻠﻟﺔﻴﻤﻳﺰﻧﻹﺍﺓﺀﺎﻔﻜﻟﺍﺮﻳﺪﻘﺗﻰﻟﺇﺔﻓﺎﺿﻹﺎﺑﺔﻴﻔﻴﻇﻮﻟﺍﺎﻬﺗﺀﺎﻔﻛﺕﺍﺮﺷﺆﻣﻭﻰﻠﻜﻟﺍ
.ﺔﻓﻭﺮﻌﻤﻟﺍﺔﻴﻠﻤﻌﻤﻟﺍﻕﺮﻄﻟﺎﺑ
ﻢﺴﺠﻟﺍﻥﺯﻭﻲﻓﺎﺤﺿﺍﻭﺎﻧﺍﺪﻘﻓﻥﺎﺴﻛﻮﻟﻷﺎﺑﺖﻨﻘﺣﻲﺘﻟﺍﺕﺎﻧﺍﻮﻴﺤﻟﺍﺕﺮﻬﻇﺃ:ﺞﺋﺎﺘﻨﻟﺍ
،ﻡﺪﻟﺍﺮﻜﺳﻲﻓﺔﺤﺿﺍﻭﺓﺩﺎﻳﺯﺕﺮﻬﻇﺃﻭ،ﻡﺪﻟﺍﻲﻓﺮﻜﺴﻟﺍﻝﺪﻌﻣﻥﺎﺼﻘﻧﻡﻭﺎﻘﺗﻢﻟﻭ
ﺔﻓﺎﺿﻹﺎﺑ.ﻦﻴﺑﻮﻠﺟﻮﻤﻴﻬﻟﺍﻚﻟﺬﻛﻭﺝ-ﺪﻴﺘﺒﺒﻟﺍﻭ،ﻦﻴﻟﻮﺴﻧﻷﺍﻝﺪﻌﻣﻲﻓﺢﺿﺍﻭﻥﺎﺼﻘﻧﻭ
ﻲﻤﻳﺰﻧﻹﺍﻁﺎﺸﻨﻟﺍﻲﻓﻭ،ﻰﻠﻜﻟﺍﻒﺋﺎﻇﻭﺕﻻﺪﻌﻣﻲﻓﺔﺤﺿﺍﻭﺕﺎﺑﺍﺮﻄﺿﺍﺙﻭﺪﺣﻰﻟﺇ
٥٤ﺓﺪﻤﻟﺪﻤﺠﻤﻟﺍﻭﻒﻔﺠﻤﻟﺍﺔﻟﻭﺍﺮﻔﻟﺍﻕﻮﺤﺴﻣﻲﻃﺎﻌﺗﻥﺃﺞﺋﺎﺘﻨﻟﺍﺕﺪﻛﺃﺎﻤﻛ.ﺪﺒﻜﻠﻟ
ﺎﺤﺿﺍﻭﺎﻨﺴﺤﺗﺮﻬﻇﺃﻥﺎﺴﻛﻮﻟﻷﺍﺐﻛﺮﻤﺑﺎﻘﺒﺴﻣﺔﻧﻮﻘﺤﻤﻟﺍﺕﺎﻧﺍﻮﻴﺤﻟﺍﻞﺒﻗﻦﻣًﺎﻣﻮﻳ
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Abstract
Objectives: Strawberries contain antioxidant phyto-
chemicals, which have been shown to beneficial against
inflammation, cardiovascular disease, cancer, obesity,
neurodegeneration, hyperglycaemia and associated dia-
betic complications. Freeze-dried strawberry powder
(FSP) is effective in controlling metabolic syndrome and
cardiovascular risk factors. The present investigation was
designed to evaluate the effect of FSP on alloxan-induced
diabetes in rats.
Methods: Diabetes was induced in male Wistar albino
rats by intraperitoneal injection of alloxan monohydrate
(150 mg/kg bw), and treatment with FSP (700 mg/day for
45 days) was started 48 h after alloxan injection. Blood
glucose, insulin, C-peptide, haemoglobin, renal function
markers (urea, uric acid and creatinine) and enzyme
markers (aspartate and alanine transaminases and alka-
line phosphatase) were assayed with suitable methods.
Results: Animals given alloxan had significant body
weight loss, poor glucose tolerance and increased blood
glucose with concomitant decreases in insulin, C-peptide
and haemoglobin values, and significant (p < 0.05)14.03.007
Effects of Fragaria x ananassa powder 269changes in the levels of renal function markers and
enzyme activities. Oral administration of FSP for 45 days
significantly (p < 0.05) reverted the body weight loss,
hyperglycaemia, biochemical parameters, enzyme activ-
ities and insulin levels to near normal levels.
Conclusions: FSP can revert alloxan-induced diabetes
and its complications. The antioxidant properties of the
fruit probably play a major role in the observed changes.
Keywords: Ellagic acid; Free radicals; Hyperglyacemia; In-
sulin; Metabolic syndrome
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Diabetes mellitus is a devastating chronic non-
communicable disease and has become a serious problem
globally: the number of diabetic patients around the world is
increasing continuously, with an estimated 371 million cases
in 2012, which is expected to reach 552 million by 2030.1
Diabetes mellitus comprises a group of chronic disorders
characterized by hyperglycaemia due to diminished insulin
secretion, which disturbs carbohydrate, lipid and protein
metabolism.2 If uncontrolled, this condition can lead to
cardiovascular disease, blindness, kidney failure and lower
limb amputation. Type 1 diabetes is an autoimmune
disease characterised by an immune complex-mediated
attack on insulin-producing b cells in the pancreas and re-
sults in lack of insulin secretion. Type 2 diabetes arises due to
either insufficient insulin synthesis or an inability to respond
to secreted insulin and leads to glucose build-up in the blood.
The pathology of diabetes mellitus includes severe metabolic
imbalances and non-physiological changes in many tissues,
in which oxidative stress plays a vital role.3 The oxidative
damage caused by reactive oxygen species during diabetes
affects in particular the kidney, liver, eyes, small and large
blood vessels and immunological and gastrointestinal
systems.3,4 Oxidative stress during diabetes has devastating
effects, due either to direct damage of cellular proteins,
lipids and DNA or to indirect effects affecting normal cell
signalling and gene regulation.5
Diabetes management with conventional treatment is
associated with adverse effects and is costly. Thus, suitable
therapy with antioxidants from natural sources, such as
plants, can benefit patients with diabetes and reduce health
care expenditure. Traditional plant-based medicines are used
throughout the world for a range of diabetic complications
and for treating diabetes mellitus.6,7 A bioflavonoid, ellagic
acid, which is abundant in strawberries, is effective against
various diabetic complications, such as retinopathy,
encephalopathy and neuropathy.8e10
Strawberries (Fragaria x ananassa) are a commercially and
economically important fruit; juices, jams and jellies are the
most popular forms. Strawberries are a healthy food choice as
theyhaveahigh content ofphytochemicals, includingvitamins,
minerals, folate, fibre and a complex mixture of polyphenols
such as flavonoids, phenolic acids, tannins, anthocyanins and
ellagitannins.11,12 These phytochemicals, either individually orcombined, are responsible for the antioxidant properties of
strawberries, and the health benefits associated with this fruit
are due to their antioxidant nature.13 The antioxidant
properties of strawberries have been well documented both
in vitro and in vivo.14e16 Strawberry fruits and leaves have
long been used for medicinal and nutritional purposes,17 and
they are considered to be an effective natural source of
protection against harmful substances and diseases.12,13,18,19
Consumption of strawberries has been associated with de-
creased incidences of various chronic pathological conditions,
including cancer, infections, obesity and neurological and
cardiovascular diseases.20,21 Strawberries and strawberry-
based phytochemicals are potential dietary sources for the
management of hyperglycaemia.22,23
To enhance their commercial value and increase their
shelf life, strawberries are processed into forms such as
frozen and dried fruits, jams, jellies, nectars and juice con-
centrates. Freeze-dried strawberry powder (FSP) retains the
polyphenol and anthocyanin content of strawberries better
than other conventional drying methods,24 and it has been
reported that FSP has more total antioxidant activity and
similar or more total polyphenol and anthocyanin content
than fresh strawberries.24,25 Consumption of FSP has
been shown to lower lipids in cardiovascular disease and to
have promising effects in metabolic syndrome and in
diabetes. Despite numerous studies of the health benefits
associated with strawberries,26,27 however, there has been
no conclusive report on their role in the management of
diabetes in vivo.
The present investigation was designed to evaluate the
effect of FSP against alloxan-induced diabetic complications
in rats.
Materials and Methods
Chemicals
Alloxan monohydrate was purchased from Sigma Chem-
ical Co. (St Louis, Missouri, USA). Diagnostic kits were
purchased from Crescent Diagnostics, Jeddah, Kingdom of
Saudi Arabia, or otherwise as mentioned in the text. FSP was
purchased from Madhu Exports, India. Only analytical-
grade chemicals were used in the study.
Experimental animals
Male albino Wistar rats weighing 160e180 g were housed
in polypropylene cages over husk bedding, and a 12-h lighte
dark cycle was maintained throughout the experiment. Rats
were fed a commercial pelleted diet and given water ad libi-
tum. Animal handling and experiments were performed in
strict adherence with the norms of the institutional animal
ethics committee.
Dosage and toxicity assessment
The hypoglycaemic response to FSP was measured at a
daily dose of 500, 600, 700 or 800 mg/kg body weight (bw)
for 15, 30, 45 or 60 days. The optimum dosage was found to
be 700 mg/kg bw per day for 45 days.16,28 Acute toxicity was
determined after administration of this dose for 15 days.
Table 1: Effect of FSP on body weight gain in control and experimental group of animals.
Group Day 1 Day 15 Day 30 Day 45
Control 165.42  0.38 184.16  1.07 192.67  0.26 199.69  0.41
Diabetes 168.58  0.92a 160.15  0.27a 155.50  0.45a 151.25  0.27a
Diabetes þ FSP 167.42  0.20b 170.12  0.52b 179.45  0.27b 184.13  0.26b
Diabetes þ glibenclamide 166.25  0.27b 173.12  0.27b 183.25  0.27b 192.14  0.27b
The values are mean  SD (n ¼ 6).
a Significantly different from control group.
b Significantly different from diabetes group.
Figure 1: Changes in blood glucose tolerance in control and dia-
betic animals given FSP or glibenclamide. Values are represented
as mean  SD for six rats in each group. Differences between a
and b are significant at p < 0.05. aAs compared with control; bas
compared with diabetic control.
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The animals were divided into four groups comprising six
animals each. One group remained untreated and served as
controls; one group consisted of alloxan-induced diabetic
rats; a third group consisted of diabetic rats treated orally
with FSP at 700 mg/kg bw per day for 45 days; and the
fourth group consisted of positive controls, which were
diabetic animals treated orally with glibenclamide at 600 mg/
kg bw per day30 for 45 days.
Diabetes was induced by a single intraperitoneal injection
of alloxan monohydrate (150 mg/kg bw) in normal saline.29
Treatment with FSP was started 48 h after alloxan injection.
At the end of the experimental period, the animals were
fasted overnight and sacrificed by decapitation.
Blood samples were collected in two test tubes for sepa-
ration of serum and plasma.
Changes in body weight gain were plotted at 15-day in-
tervals for 45 days. The glucose tolerance test was performed
by administering 2 g/kg bw glucose to animals fasted over-
night and measuring the glucose concentration at 30-min
intervals for 2 h. Blood glucose, urea, plasma protein,
serum creatinine, uric acid and the enzymes aspartate
transaminase (AST), alanine transaminase (ALT) and alka-
line phosphatase (ALP) were assayed with standard diag-
nostic kit reagents. Plasma insulin and C-peptide were
assayed with an enzyme-linked immunosorbent assay
(ELISA) kit (Boehringer Mannheim, Germany). Haemo-
globin and glycosylated haemoglobin were measured by the
methods of Drabkin and Austin31 and Nayak and
Pattabiraman,32 respectively. Urinary strips were used to
detect urine sugar.
Statistical methods
Data were analysed with SPSS version 16 for Windows.
One-way analysis of variance (ANOVA) and a test for least
significant difference were performed, with a level of signif-
icance at p < 0.05 between the control and other groups of
animals. All the results are expressed as means  SD for the
six animals in each group.
Results
No acute toxicity was observed (data not shown). Table 1
and Figure 1 show the changes in body weight and glucose
tolerance in the two experimental groups, respectively.
Body weight gain was significantly decreased in diabetic
animals, which showed a rapid increase in blood glucoseduring the first 60 min of the glucose tolerance test over
that of controls. Administration of FSP improved glucose
tolerance and significantly reversed the body weight loss.
Table 2 shows a statistically significant increase in blood
glucose and glycosylated haemoglobin with a concomitant
decrease in haemoglobin values in diabetic animals, which
were reduced to normal values in the groups treated with
FSP and in the glibenclamide-treated group.
Figure 2 shows the variations in insulin and C peptide in
the experimental groups. The control animals showed no
significant alterations during the study, while the diabetic
animals showed decreased values. FSP reverted the altered
levels to those of the control group.
Table 3 shows the elevated levels of total proteins and
concomitant decreases in urea, uric acid and creatinine in
diabetic animals. Treatment with FSP significantly restored
these levels nearly to normal.
The serum levels of AST, ALT and ALP in the four
groups are shown in Figure 3. The activities were reduced in
the diabetic group but returned nearly to the original values
after treatment with FSP or glibenclamide.
Discussion
The results of this preliminary study clearly show that FSP
can reverse alloxan-induced diabetes. Body-weight loss after
alloxan induction might be due to greater muscle wasting,
increased catabolism of tissue proteins and loss of structural
proteins; oral administration of FSP restored body-weight
Table 2: Effect of FSP on blood glucose, haemoglobin, glycosylated haemoglobin and urine sugar levels in control and experimental
group of animals.
Groups Blood glucose (mg/dl) Hemoglobin (g/dl) Glycosylated haemoglobin (Hb%) Urine sugar
Control 80.34  3.12 13.98  0.78 5.98  0.34 Nil
Diabetic Control 284.12  8.56a,* 7.68  0.45a,* 13.28  0.33a,* þþþ
Diabetic þ FSP 100.34  3.99b,* 12.1  0.34b,* 7.12  0.13b,* Nil
Diabetic þ Glibenclamide 92.12  1.67b,* 12.13  0.13b,* 6.12  0.31b,* Nil
The values are mean  SD (n ¼ 6); þþþ indicates more than 2% sugar.
*p < 0.05.
a Significantly different from control group.
b Significantly different from diabetic control group.
Figure 2: Effect of FSP on plasma insulin and C peptide levels in
control and diabetic animals. Values are represented as
mean  SD for six rats in each group. Differences between a and b
are significant at p < 0.05. aAs compared with control; bas
compared with diabetic control.
Effects of Fragaria x ananassa powder 271gain by maintaining protein turnover and ensuring better
glycaemic control. Similar glycaemic control was reported in
mice with FSP treatment.33 The high fibre and flavonol
content of strawberries12,34 may be responsible for the
favourable glycaemic response, as found with other
berries.35e37 The impaired glucose tolerance in alloxan
diabetes is due to a series of cellular events that leads to
pancreatic b cell degeneration and hypoinsulinemia.38
Increased blood glucose persisted throughout oral glucose
challenge in the diabetic animals, but 45 days of FSP
treatment resulted in a regular pattern of glucose tolerance,Table 3: Effect of FSP on the levels of total proteins, blood urea, serum
group of animals.
Group Total protein (g/dl) Blood urea (m
Control 8.15  0.38 22.1  2.10
Diabetic Control 6.13  0.26a,* 45.16  4.98a
Diabetic þ FSP 6.78  0.15b,* 28.13  1.67b
Diabetic þ Glibenclamide 7.13  0.45b,* 30.12  2.54b
The values are mean  SD (n ¼ 6).
*p < 0.05.
a Significantly different from control group.
b Significantly different from diabetic control group.indicating the ability of FSP to influence cellular uptake of
glucose.
The pathophysiology of alloxan toxicity is attributed to
its ability to produce reactive oxygen species. This pancreatic
toxin is rapidly taken up by b cells and produces reactive
oxygen species through a dialuric acid-mediated cyclic re-
action. Autoxidation of dialuric acid generates various free
radicals, including superoxide radicals, hydrogen peroxide,
hydroxyl radicals and even an alloxan radical intermediate,39
which reduce insulin production and enhance blood glucose.
Hyperglycaemia leads to non-enzymatic glycosylation of
haemoglobin during diabetes.40 The inverse association
between glycosylated haemoglobin and haemoglobin is
directly proportional to the fasting blood glucose level.41
Increased blood glucose, decreased plasma insulin,
decreased C peptide and associated changes in urine sugar,
haemoglobin and glycosylated haemoglobin are all typical
features of alloxan-induced diabetes.42,43 All of these
factors were normalised by oral administration of FSP to
diabetic rats in the present investigation.
The anti-diabetic function of FSP might be due to pro-
tection of pancreatic b cells against free radical-induced
damage by alloxan. The reversal of blood glucose and of
plasma insulin levels in this study might be due to the ability
of FSP to induce and secrete insulin from pancreatic b cells.
The presence of various antioxidants in strawberries44 was
therefore responsible, as strawberry consumption has been
reported to reduce blood glucose.33 Strawberry components
such as ellagic acid and other flavonoids have been shown
to have anti-diabetic activity in animal models.45,46
Alloxan-induced reactive oxygen species damage not only
pancreatic b cells but also other tissues, such as the liver.35
Alloxan-induced free radicals degrade proteins and damageuric acid and serum creatinine levels in control and experimental
g/dl) Serum uric acid (mg/dl) Serum creatinine (mg/dl)
1.98  0.14 0.45  0.08
,* 4.98  0.56a,* 1.18  0.26a,*
,* 3.01  0.26b,* 0.54  0.05b,*
,* 2.63  0.11b,* 0.53  0.03b,*
Figure 3: Effect of FSP on serum transaminase (AST and ALT)
and alkaline phosphatase (ASP) activities. AST and ALT activity
in mmol pyruvate/h per mg protein; ALP activity in mmol phenol
liberated/min per mg of protein. Values are represented as
mean  SD for six rats in each group. Differences between a and b
are significant at p < 0.05. aAs compared with control; bas
compared with diabetic control.
S. Sheik Abdulazeez272membrane phospholipids through lipid peroxidation. He-
patocellular membrane damage results in release of AST,
ALT and ALP into the bloodstream, which confirms the
hepatotoxic nature of alloxan.43 Treatment of diabetic rats
with FSP restored the enzyme activities in serum to near
normal values, which confirms the ability of FSP to
alleviate liver damage in alloxan diabetes. This hepato-
protective function of FSP has been reported previously.47
It may be associated with the fact that polyphenolic
fractions of berries suppress the inflammatory response.48
Diabetic hyperglycaemia increases serum urea, uric acid
and creatinine levels,49,50 indicating renal dysfunction and
reduced glomerular filtration. Alloxan-induced free radical-
mediated breakdown of both liver and plasma proteins
leads to the accumulation of urea nitrogen and an associated
increase in uric acid in experimental diabetes.49 Mostly of the
increase in creatinine is associated with a concomitant
increase in blood urea nitrogen. Administration of FSP for
45 days resulted in reversal of these parameters to near
normal values. Tulipani et al.16 demonstrated that
consumption of strawberries helps to maintain the uric acid
and albumin levels in serum. The results of the present
study concur with that report and suggest that polyphenols
and vitamin C in strawberries are responsible for restoring
these biochemical markers in alloxan diabetes.16,51Conclusions
The emerging literature on the health benefits of straw-
berries prompted the present evaluation of the anti-diabetic
potential of FSP in free radical-mediated alloxan diabetes.
The results of this preliminary study, the first of its kind,
clearly suggest that FSP can revert alloxan-induced diabetes.
Antioxidants in the fruit play a major role in the observed
changes. Further studies with individual strawberry phyto-
chemicals would provide more insight into the anti-diabetic
action of strawberries.Conflict of interest
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